mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.06 |